MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature

Tuberculosis (TB) is accountable for considerable global morbidity and mortality. Effective TB therapy with multiple drugs completes in about six months. The longer duration of TB therapy challenges patient compliance and contributes to treatment collapse and drug resistance (DR) progress. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Imran, Mohd., Arora, Mandeep Kumar, Chaudhary, Anurag, Khan, Shah Alam, Kamal, Mehnaz, Alshammari, Manal Mutlaq, Alharbi, Raghad Mohammad, Althomali, Nuha Abdullah, Alzimam, Ibrahim Mohammed, Alshammari, Abdullah Ayed, Alharbi, Bashair Hamed, Alshengeti, Amer, Alsaleh, Abdulmonem A., Alqahtani, Shayea A., Rabaan, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687596/
https://www.ncbi.nlm.nih.gov/pubmed/36359313
http://dx.doi.org/10.3390/biomedicines10112793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687596/
https://www.ncbi.nlm.nih.gov/pubmed/36359313
http://dx.doi.org/10.3390/biomedicines10112793

Ejemplares similares